Your browser doesn't support javascript.
loading
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.
Joharatnam-Hogan, Nalinie; Hatem, Duaa; Cafferty, Fay H; Petrucci, Giovanna; Cameron, David A; Ring, Alistair; Kynaston, Howard G; Gilbert, Duncan C; Wilson, Richard H; Hubner, Richard A; Swinson, Daniel E B; Cleary, Siobhan; Robbins, Alex; MacKenzie, Mairead; Scott-Brown, Martin W G; Sothi, Sharmila; Dawson, Lesley K; Capaldi, Lisa M; Churn, Mark; Cunningham, David; Khoo, Vincent; Armstrong, Anne C; Ainsworth, Nicola L; Horan, Gail; Wheatley, Duncan A; Mullen, Russell; Lofts, Fiona J; Walther, Axel; Herbertson, Rebecca A; Eaton, John D; O'Callaghan, Ann; Eichholz, Andrew; Kagzi, Mohammed M; Patterson, Daniel M; Narahari, Krishna; Bradbury, Jennifer; Stokes, Zuzana; Rizvi, Azhar J; Walker, Georgina A; Kunene, Victoria L; Srihari, Narayanan; Gentry-Maharaj, Aleksandra; Meade, Angela; Patrono, Carlo; Rocca, Bianca; Langley, Ruth E.
Afiliación
  • Joharatnam-Hogan N; MRC Clinical Trials Unit, UCL, London, UK.
  • Hatem D; Department of Safety and Bioethics, Division of Pharmacology, Catholic University School of Medicine, Rome, Italy.
  • Cafferty FH; MRC Clinical Trials Unit, UCL, London, UK.
  • Petrucci G; The Institute of Cancer Research, London, UK.
  • Cameron DA; Department of Safety and Bioethics, Division of Pharmacology, Catholic University School of Medicine, Rome, Italy.
  • Ring A; Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, The University of Edinburgh, Western General Hospital, Edinburgh, UK.
  • Kynaston HG; The Institute of Cancer Research, London, UK.
  • Gilbert DC; The Royal Marsden NHS Foundation Trust, London, UK.
  • Wilson RH; Department of Urology, Cardiff University School of Medicine, Cardiff, UK.
  • Hubner RA; MRC Clinical Trials Unit, UCL, London, UK.
  • Swinson DEB; University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
  • Cleary S; School of Cancer Sciences, University of Glasgow, Glasgow, UK.
  • Robbins A; The Beatson West of Scotland Cancer Centre, Glasgow, UK.
  • MacKenzie M; The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, UK.
  • Scott-Brown MWG; University of Manchester, Division of Cancer Sciences, Manchester, UK.
  • Sothi S; Leeds Teaching Hospitals NHS Trust, Leeds, UK.
  • Dawson LK; MRC Clinical Trials Unit, UCL, London, UK.
  • Capaldi LM; MRC Clinical Trials Unit, UCL, London, UK.
  • Churn M; Independent Cancer Patients' Voice, London, UK.
  • Cunningham D; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
  • Khoo V; University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK.
  • Armstrong AC; Edinburgh Cancer Centre, Western General Hospital, Edinburgh, UK.
  • Ainsworth NL; Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
  • Horan G; Worcestershire Acute Hospitals NHS Trust, Worcester, UK.
  • Wheatley DA; The Royal Marsden NHS Foundation Trust, London, UK.
  • Mullen R; The Institute of Cancer Research, London, UK.
  • Lofts FJ; The Royal Marsden NHS Foundation Trust, London, UK.
  • Walther A; The Christie NHS Foundation Trust, Department of Medical Oncology, Manchester, UK.
  • Herbertson RA; The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK.
  • Eaton JD; The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK.
  • O'Callaghan A; Royal Cornwall Hospitals NHS Trust, Cornwall, UK.
  • Eichholz A; The Highland Breast Centre, Raigmore Hospital, Inverness, UK.
  • Kagzi MM; St George's University Hospitals NHS Foundation Trust, London, UK.
  • Patterson DM; University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Narahari K; University Hospitals Sussex NHS Foundation Trust, Brighton, UK.
  • Bradbury J; University Hospitals of Morecambe Bay NHS Foundation Trust, Kendal, UK.
  • Stokes Z; Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
  • Rizvi AJ; Buckinghamshire Healthcare NHS Trust, Buckinghamshire, UK.
  • Walker GA; South Tees Hospitals NHS Foundation Trust, Middlesbrough, UK.
  • Kunene VL; West Suffolk Hospitals NHS Trust, St Edmunds, UK.
  • Srihari N; University Hospital of Wales, Cardiff and Vale University Health Board, Cardiff, UK.
  • Gentry-Maharaj A; Division of Cancer and Genetics, Cardiff University, Cardiff, UK.
  • Meade A; Salisbury NHS Foundation Trust, Salisbury, UK.
  • Patrono C; United Lincolnshire Hospitals NHS Trust, Lincoln City, UK.
  • Rocca B; Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK.
  • Langley RE; Nottingham University Hospitals NHS Trust, Nottingham, UK.
Br J Cancer ; 129(4): 706-720, 2023 09.
Article en En | MEDLINE | ID: mdl-37420000
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Aspirina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Neoplasias Colorrectales / Aspirina Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Br J Cancer Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido